No Data
No Data
MIRA Pharmaceuticals Appoints New Board Member and Chairman
Express News | Mira Pharmaceuticals Announced The Selection Of The Centre For Human Drug Research In Leiden, The Netherlands, As The Site For Its Phase I/IIa Clinical Trial Of Ketamir-2, A Novel Oral Ketamine Analog
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site
US Manufacturing Index Rises To 43, Highest Since 2020
MIRA Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Trending Stocks Today | Pixie Dust Technologies Shoots up 186.56% Post-Market
No Data
No Data